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Despite marked improvements in developmental out-
come with newborn screening and early levothyroxine
replacement most follow up studies of congenital
hypothyroidism (CH) show a persistent mild deficit
in total IQ. It has been considered that these deficits in
neurocognitive function occur in utero and thus even
early therapy cannot completely normalise development.
Alternatively the deficits could be caused by delayed
diagnosis and inadequate early treatment. In Auckland,
early diagnosis occurs via our newborn screening pro-
gramme along with an aggressive high dose treatment
paradigm following referral to the endocrine service.
Thus we hypothesised that early diagnosis and aggressive
therapy with close monitoring would result in normal
neurocognitive outcomes.
Methods
A blinded prospective sibling-matched study was under-
taken. Subjects were otherwise healthy children and
adolescents aged 4 to 18 years. Exclusion criteria for
both CH subjects and sibling controls included chronic
illness, other congenital problems or documented devel-
opmental delay, cerebral palsy or other disability.
Assessments included WPPSI for children under 7 years
old, WISC IV for children > 7 years and several tests of
motor function including the Berry assessment of visual
motor function, PPVT and ABC. Auxological data were
collected and body composition was assessed using
DEXA scans.
49 children with CH and 53 sibling controls were
recruited. Control subjects were younger (8.5 vs 10.4
years) but had similar gender proportions (54%female vs
60% female), height SDS (0.81 vs 0.84) and weight SDS
(1.05 vs 0.97). In the CH group, 22% had athyreosis,
20% had dyshormonogenesis and 57% had ectopia.
Average time to diagnosis was 12 ± 6.7 days and free
T4 was normal by 16.6 ± 5.7 days. There was no differ-
ence in Verbal IQ between control and CH subjects
(93.6 vs 96.7), Overall IQ (95.2 vs 95.1) although there
was a trend to better processing speed in the control
subjects (97.3 vs 95.1; p=0.07). There was no difference
between groups for motor function although there was
a trend to better overall ABC scores in the CH group
(60.9 ± 29.8% vs 49.7 ± 29%; p=0.06). There were no
differences in body composition between the two groups
although BMD trended to being lower in the CH group
(0.90 vs 0.98; p=0.067). There was no association with
developmental outcomes and the age at diagnosis.
Conclusion, the current Auckland diagnosis and treat-
ment paradigm results in neurocognitive outcomes no
different to siblings. BMD was lower in the CH group,
possibly suggesting the children have been mildly over
treated.
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